Divya Mohan - Concepedia

Author

Divya Mohan

Also Known As

Aishwarya T A, D Mohan, D. Chandra Mohan, D. Mohan, DIVYA MOHAN, Divya K. Mohan, Divya K． Mohan, Divya Mohan, Mohan, D, Mohan, Divya

115

Publications

856

Citations

H-Index

Concepts

All Affiliations

University of Cambridge GlaxoSmithKline (United States)Cambridge University Hospitals NHS Foundation Trust Royal Brompton & Harefield NHS Foundation Trust Imperial College London

About

Divya Mohan is an author at University of Cambridge specializing in medicine, rehabilitation, and pulmonary disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	268
2	Health Sciences	2	2	136
3	Education	1	1	68
4	Public Health	1	1	21
5	Applied Physiology	1	1	46

Divya Mohan

Publications

628

Citations

H-Index

Page 1

	Year	Citations
Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity Heleen Demeyer, Divya Mohan, Chris Burtin, Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Pa EndpointPhysical ActivityMeasured Physical ActivityHealth PolicyExercise Prescriptions	2021	90
Phenotypic Characteristics Associated With Reduced Short Physical Performance Battery Score in COPD Mehul S. Patel, Divya Mohan, Yvonne M. Andersson, CHEST Journal Pulmonary CareFitnessPhysical FitnessPhysiologyPhenotypic Characteristics Associated	2013	68
Effects of Pelvic Stability Training on Movement Control, Hip Muscles Strength, Walking Speed and Daily Activities after Stroke: A Randomized Controlled Trial Lavnika Dubey, Suruliraj Karthikbabu, Divya Mohan Annals of Neurosciences Gait AnalysisHip Muscles StrengthPhysical ActivityMovement BiomechanicsNeurological Rehabilitation	2018	46
Evaluation of anti-hypertensive activity of Ulmus wallichiana extract and fraction in SHR, DOCA-salt- and L-NAME-induced hypertensive rats Syed Anees Ahmed, Shibani Lahiri, Divya Mohan, Journal of Ethnopharmacology HypertensionAnti-hypertensive ActivityL-name-induced Hypertensive RatsMedicineAntihypertensive Therapy	2016	43
Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation Christopher Coello, Marie Fisk, Divya Mohan, EJNMMI Research	2017	35
Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease Marie Fisk, Carmel M. McEniery, Nichola Gale, Hypertension	2018	35
Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease Jilles M. Fermont, Divya Mohan, Marie Fisk, Age and Ageing	2020	34
CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin Holly R. Keir, Hollian Richardson, Christina Fillmore, ERJ Open Research	2020	32
Cardioprotective Effect of Ulmus wallichiana Planchon in β-Adrenergic Agonist Induced Cardiac Hypertrophy Syed Anees Ahmed, Shibani Lahiri, Divya Mohan, Frontiers in Pharmacology	2016	31
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial Marie Fisk, Joseph Cheriyan, Divya Mohan, PLoS ONE	2018	30

Page 1